Results 151 to 160 of about 2,253 (164)

European regulatory experience with drugs for central nervous system disorders

Nature Reviews Drug Discovery, 2014
Guido Rasi
exaly  

Securing the future of drug discovery for central nervous system disorders

Nature Reviews Drug Discovery, 2014
Barbara J Sahakian, Anthony G Phillips
exaly  

Neurosurgical management of metastases in the central nervous system

Nature Reviews Clinical Oncology, 2011
Elizabeth B Claus
exaly  

<p>Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders</p>

International Journal of Nanomedicine, 2019
Maryam Ghasemi-Kasman, Marzieh pirzadeh
exaly  

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015

Neuro-Oncology, 2018
Quinn T Ostrom, Haley Gittleman, Carol Kruchko Ba   +2 more
exaly  

Challenges in drug development for central nervous system disorders: a European Medicines Agency perspective

Nature Reviews Drug Discovery, 2016
Lorenzo Guizzaro
exaly  

Primary central nervous system tumors: advances in knowledge and treatment

Ca-A Cancer Journal for Clinicians, 1998
exaly  

Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration

Advanced Materials, 2019
Duo Xu, Di Wu, Lina R Nih
exaly  

Central nervous system tumors: what have we learned and where are we heading?

Ca-A Cancer Journal for Clinicians, 1998
exaly  

A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System

Advanced Materials, 2019
Di Wu, Duo Xu, Lan Wang
exaly